LSU Health New Orleans research finds new Rx target for childhood cancer

(Louisiana State University Health Sciences Center) Research led by Michael Lan, Ph.D., Professor of Pediatrics and Genetics at LSU Health New Orleans School of Medicine, found that a compound named 5'-iodotubercidin (5'-IT) suppresses the growth of neuroblastoma cells and identified a potential new therapeutic approach for the disease.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news